Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2022

Hozzl · 2022-12-29T19:03:39Z

Explore the details of House Bill 8724 Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2022 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/29/2022, 7:03 PM

Summary of Bill HR 8724

Bill 117 HR 8724, also known as the Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2022, aims to improve the safety and regulation of menstrual products and intimate care products in the United States. The bill is named after Robin Danielson, a young woman who tragically passed away due to toxic shock syndrome caused by a tampon in 1988.

The key provisions of the bill include requiring manufacturers of menstrual products and intimate care products to disclose all ingredients used in their products, including any potentially harmful chemicals. This transparency will allow consumers to make more informed choices about the products they use.

Additionally, the bill calls for the establishment of a task force to study the safety of menstrual products and intimate care products, and to make recommendations for improving regulations and oversight in this industry. This task force will also be responsible for conducting research on the potential health risks associated with these products. Furthermore, the bill includes provisions to increase funding for research into menstrual health and hygiene, as well as education and outreach programs to raise awareness about the importance of safe and healthy menstrual practices. Overall, the Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2022 seeks to protect the health and well-being of consumers by ensuring that menstrual products and intimate care products are safe, regulated, and transparent.

Congressional Summary of HR 8724

Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2022

This bill requires the National Institutes of Health to conduct or support research on the extent to which components (including contaminants and substances used as fragrances, colorants, dyes, and preservatives) in menstrual products and intimate care products pose health risks to people who use the products or to the children of people who use the products during or before pregnancy.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 8724

Bill HR 8724 is currently in the status of Bill Introduced since August 16, 2022. Bill HR 8724 was introduced during Congress 117 and was introduced to the House on August 16, 2022. Bill HR 8724's most recent activity was Referred to the House Committee on Energy and Commerce. as of August 16, 2022

Bipartisan Support of Bill HR 8724

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 8724

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 8724

Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2022Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2022To amend the Public Health Service Act to establish a program of research regarding the risks posed by the presence of dioxins, phthalates, pesticides, chemical fragrances, and other components of menstrual products and intimate care products.

Start holding our government accountable!